The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 16,657,500 | 125,000 | SH | Call | SOLE | 0 | 0 | 0 | |
| ALUMIS INC | COM | 022307102 | 2,151,556 | 76,459 | SH | SOLE | 76,459 | 0 | 0 | ||
| AN2 THERAPEUTICS INC | COM | 037326105 | 2,547,365 | 526,315 | SH | SOLE | 526,315 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | 3,847,200 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| AVALO THERAPEUTICS INC | SPONSORED ADS | 05338F306 | 2,772,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | 4,036,992 | 16,493 | SH | SOLE | 16,493 | 0 | 0 | ||
| CLIMB BIO INC | COM | 28658R106 | 3,249,203 | 249,172 | SH | SOLE | 249,172 | 0 | 0 | ||
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | 2,906,250 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | ||
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | 18,816,000 | 400,000 | SH | Call | SOLE | 0 | 0 | 0 | |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 3,384,479 | 83,300 | SH | SOLE | 83,300 | 0 | 0 | ||
| EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | 1,666,877 | 252,175 | SH | SOLE | 252,175 | 0 | 0 | ||
| FIRST TRACKS BIOTHERAPEUTICS | ORD SHS | 337185102 | 5,719,854 | 284,287 | SH | SOLE | 284,287 | 0 | 0 | ||
| IBIO INC | COM NEW | 451033708 | 682,757 | 390,147 | SH | SOLE | 390,147 | 0 | 0 | ||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 2,515,725 | 67,500 | SH | SOLE | 67,500 | 0 | 0 | ||
| INVENTIVA SA | ADS | 46124U107 | 2,399,544 | 634,800 | SH | SOLE | 634,800 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 3,181,300 | 290,000 | SH | SOLE | 290,000 | 0 | 0 | ||
| MINERVA NEUROSCIENCES INC | COM NEW | 603380205 | 12,075,701 | 2,175,802 | SH | SOLE | 2,175,802 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 1,680,069 | 624,561 | SH | SOLE | 624,561 | 0 | 0 | ||
| PALISADE BIO INC | COM | 696389402 | 2,568,610 | 1,229,000 | SH | SOLE | 1,229,000 | 0 | 0 | ||
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | 2,536,897 | 743,958 | SH | SOLE | 743,958 | 0 | 0 | ||
| PROMIS NEUROSCIENCES INC | COM SHS | 74346M505 | 8,163,398 | 620,319 | SH | SOLE | 620,319 | 0 | 0 | ||
| SOLID BIOSCIENCES INC | COM | 83422E204 | 2,557,030 | 255,959 | SH | SOLE | 255,959 | 0 | 0 | ||
| TRAWS PHARMA INC | COM | 68232V884 | 663,033 | 786,236 | SH | SOLE | 786,236 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 2,545,934 | 69,183 | SH | SOLE | 69,183 | 0 | 0 | ||
| WHITEHAWK THERAPEUTICS INC | COM | 00032Q104 | 3,746,161 | 817,939 | SH | SOLE | 817,939 | 0 | 0 | ||